White Paper
Five Translational Insights Key to a Successful First-in-Human (FIH) Study
Closer to the phenotype, faster.
While genomics, transcriptomics and proteomics are well-established tools in the drug development arsenal, these tools stop short of providing a definitive representation of the clinical phenotype. Metabolomics can augment the power and utility of these tools by providing an in vivo functional snapshot of all upstream biologic processes, helping you get closer to the phenotype and reveal incremental insights that can increase confidence in your drug development decisions.
Learn how metabolomics is uniquely able to bridge between the theoretical and practical to deliver functional understanding of your drug candidate activity across species.
